• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Formulary
    • Exclusives
    • Top Companies
    • Raw Materials
    • End-User
    • Packaging
    • Directories
    • Events
    • Jobs
    • More
  • Magazine
  • News
  • Formulary
  • Exclusives
  • Top Companies
  • Raw Materials
  • End-User
  • Packaging
  • Directories
  • Events
  • Jobs
  • Current / Back Issues
    Features
    Columns
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    In Sickness & in Health

    In Action

    Tress Test

    From Hollywood to Hair Color

    Virtual Reality for Makeup Is Not Make Believe
    Online Exclusives
    Association News
    Breaking News
    Financial News
    Industry News
    International
    Marketing News
    New Products
    News Front
    Packaging News
    Patents
    Personnel
    Regulations
    Snapshots
    Top News
    Live From Shows
    Top News
    T-Boz Launches CBD Line

    DRF and Flowerkist Develop CBD Range

    Offprice Show to Host Beauty Popup

    Mary Kay Advocates for Equality

    Derma E Adds CBD
    Blog
    Online Exclusives
    Infographics
    Podcasts
    Whitepapers
    Videos
    Expert's Opinion
    eBook
    Surveys
    International Top 30 Report
    Top 50 Report
    Top Companies
    25. Lornamead

    45. State

    1. Procter & Gamble

    5. Kao

    29. Menard
    Actives
    Functional Ingredients
    Pigments
    Polymers
    Preservatives
    Surfactants

    Treasuring Textured Hair

    USDA Certified Organic CBD Products Emerge

    Nail Enamel Gets Greener

    Givaudan Unveils RitualEssenz Brazil

    Where Angels Soar
    Air Care/Environmental Fragrance
    AP/Deo
    Color Cosmetics
    Disinfectants
    Fine Fragrance
    Hair Care
    Household Cleaning
    I&I Marketplace
    Laundry Care
    Oral Care
    OTC/Medicated
    Packaging
    Personal Cleansers
    Skin Care
    Sun Care
    Testing

    T-Boz Launches CBD Line

    DRF and Flowerkist Develop CBD Range

    Offprice Show to Host Beauty Popup

    Derma E Adds CBD

    Treasuring Textured Hair
    Lab Equipment
    Mixing
    Packaging
    Testing

    Seven of the Best Ideas in Beauty Sustainability

    Love Beauty and Planet Addresses Waste

    A New Era in Efficacy Testing

    Circular Models for Consumer Staples

    CPI Works to Reduce Formulation Risks
    Contract Manufacturing / Private Label Directory
    Buyer's Guide
    Add New Company
    Corporate Profiles
    International Buyers Guide Companies
    Siltech Corporation

    CIE

    Croda

    Sabinsa Cosmetics, a division of Sabinsa Corporation

    Ashland
    Live From Shows
    Meetings
    Webinars
    Snapshots
    • Magazine
      • Current / Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Formulary
    • Directories
      • Buyer's Guide
      • Contract Manufacturing / Private Label Directory
      • Corporate Profiles
      • Add Your Company
    • Raw Materials
      • Actives
      • Functional Ingredients
      • Pigments
      • Polymers
      • Preservatives
      • Surfactants
    • End-User
      • Air Care/Environmental Fragrance
      • AP/Deo
      • Color Cosmetics
      • Disinfectants
      • Fine Fragrance
      • Hair Care
      • Household Cleaning
      • I&I Marketplace
      • Laundry Care
      • Oral Care
      • OTC/Medicated
      • Packaging
      • Personal Cleansers
      • Skin Care
      • Sun Care
      • Testing
    • Packaging
      • Lab Equipment
      • Mixing
      • Packaging
      • Testing
    • Top Companies
      • International Top 30 Report
      • Top 50 Report
    • Online Exclusives
    • Experts Opinion
    • Slideshows
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Blog
    • Whitepapers
    • Surveys
      • R & D Salary Survey
      • Sales & Marketing Salary Survey
    • Job Banks
    • Events
      • Industry Events
      • Live from show Events
      • Webinars
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Sunscreen Filter

    Are The Odds Stacked Against Sunscreen Use?

    Related CONTENT
    • L’Oreal Paris Starts Global Outreach
    • Oral Care Kit Recall
    • Sure-Fire Strategies for Cultivating Consumer Credibility
    • What's Not to Love?
    • Lush Is Flush with Novel Ideas
    Nadim Shaath, Alpha Research & Development Ltd06.01.17
    Recent calls echo loud and clear against the safe, effective use of sunscreens to prevent skin cancer. They emanate from the four corners of the world and include the US Food and Drug Administration (FDA), environmentalists worldwide, and even toxicologists and researchers around the globe.  Of course, the internet lights up whenever negative research about sunscreens surfaces; if you’re on Facebook, Instagram or Twitter, or simply Google citations, these negative messages stare you right in the face from your computer screen.

    Our cosmetic and sunscreen industry, and most dermatologists, have advocated the safe use of sunscreen products as one of the most important regimens for protection against skin cancer. Together with sun abstinence, use of protective clothing, hats and umbrellas, sun care products have enjoyed a surge of consumer use with double-digit growth in worldwide sales for years. Many studies, such as those of Green, Hacker, Ghiasvand, Burd and others, have demonstrated the effectiveness of using sunscreen lotions and creams for protection and abating the risk of skin cancer due to overexposure. Unfortunately, skin cancer is still on the rise and has reached epidemic proportions—it still ranks as the single most prevalent cancer today. With nearly 3.5 million cases of skin cancer diagnosed annually in about 2.2 million patients in the US, including over 80,000 cases of deadly malignant melanomas, protection is paramount.

    Let me first enumerate the many citations and arguments of individuals, organizations and advocacy groups that have joined the chorus bemoaning the pitfalls of using sunscreens for cancer protection.

    Starting from the top, the US FDA is largely responsible for the chaos and uncertainty that industry and consumers are experiencing today. Consider the statement made to Congressional aides by the FDA’s Theresa Michele, the director of Nonprescription Drug Products (NPDP), that “not everyone can get skin cancer from the sun, but everyone can get skin cancer from sunscreens.” 

    Imagine a 50-year-old thriving industry that has never ever had final regulations. Since the early 1970s, there have been calls for regulations in the field of sunscreens. An expert panel was convened and the first regulation, the Advanced Notice of Proposed Rulemaking (ANPR) was issued in August 1978. It listed 21 UV filters at specified ranges that would be deemed safe and effective to “prevent skin cancer.” Fifteen years later, in 1993, the Tentative Final Monograph was issued; and nearly 15 years passed before the Proposed Final Rules were issued in August 2007. Finally, the Final Rule was issued in June 14, 2011 and was implemented in December 2012. But wait! That was not the Final Monograph but rather the Final Rule that only states that a sunscreen product must comply with the three following conditions:
    1. A minimum of SPF 15;
    2. A Broad Spectrum claim (Critical Wavelength) and
    3. A modified Principal Display Panel-Drug Facts.
    No decision was made then (2011) on the eight pending Time and Extent Application (TEA) sunscreen ingredients. Also, no limit was set on SPF (hence the soaring and chaotic SPF numbers we see today), no decision was made on the safety of sprays, combinations with avobenzone, or a host of other issues. If a sunscreen product complies with the above three conditions, then cosmetic companies can now make the following “drug” claim: “Sunscreens reduce the risk of skin cancer and early skin aging when used as directed.”

    Blame FDA…
    The use of this drug claim by the “eager” and “over anxious” sunscreen and cosmetic industry is the reason why the FDA treats regulations of sunscreens in the same vein as it treats a cancer treatment drug, a cholesterol-reducing drug, a blood pressure lowering drug or a heart failure treatment drug!  How can a product, which presumably does not alter any biological function in the body, be treated as a drug and not just a cosmetic that simply reflects or absorbs harmful ultraviolet radiation?  Most countries around the world consider sunscreens as cosmetics not drugs. In the US, drug approval is a drawn out, extensive and expensive proposition requiring millions of dollars and a half dozen years to complete all the elaborate testing and requirements to comply with drug standards established by the FDA.

    Another consequence of treating sunscreens as drugs has been the restriction imposed by authorities in schools, camps, public pools and beaches requiring parental permission for using sunscreens on children. Fortunately, a few states (including Louisiana, Washington and Arizona) are currently passing legislation for the free use of sunscreens in schools and, in effect, distinguishing between sunscreens and other OTC drugs administered to children in the school.

    …and the Industry!
    Unfortunately, the second culprit in the chaotic sunscreen protection scene is the sun care industry itself. We shouldn’t have touted our products as regimens to protect consumers from skin cancer.  Rather, we should have been satisfied with claiming only that effective use of these products reflects or absorbs the solar radiation (mostly ultraviolet), the consequence of which may reduce the effects of exposure to the harmful rays of the sun.

    The industry should be more engaged in education and advocate for the safe use of sunscreens. When false or negative information surfaces—whether unsubstantiated internet reports or substantiated medical, environmental or scientific studies—the industry should react and respond appropriately. These responses must come from individual companies as well as from advocacy groups, whose response to a host of negative issues that surfaced during the past decade have been dismal.  Even the Personal Care Product Council rarely reacts and issues statements or convenes studies to refute those claims. The American Academy of Dermatology is better at responding to cancer and dermatological threats caused by sunscreens but it too, is not totally effective.

    Other threats to the sun care industry that I have highlighted in previous columns have come from a multitude of sources and include the following claims:
    1. Sunscreens decrease vitamin D levels.
    2. Sunscreens destroy coral reefs.
    3. Spray sunscreens are the new “second hand smoke.”
    4. Oxybenzone is an endocrine disruptor.
    5. Sunscreens destroy oyster beds.
    6. Half of the sunscreens tested had an SPF below their label SPF.
    7. 40% of sunscreens did not adhere to AAD guidelines.
    8. Sunscreens disrupt sperm cell function.
    Well, you get the picture.

    Sunscreens are under attack. Their efficacy and safety are being questioned.  Skin cancer is on the rise. Disastrous tanning booths are still frequented. Regulations are still not forthcoming.  Basic research on new effective ultraviolet filters has been virtually eliminated in the US.  Who will spend considerable time and money on research that can never be implemented and eventually commercialized?  What can be done?  What should be done?

    I have many thoughts and ideas.  Please email me with suggestions and plans to reverse this negative trend. Sunscreen use may not be a panacea, but certainly, when used effectively and appropriately, it should be our first line of defense against the ravaging rays of the sun. I will share my thoughts and yours in my next column entitled “The Case for Using Sunscreens.


    Nadim Shaath
    Alpha Research & Development Ltd
    Email: alpharnd@aol.com

    Dr. Nadim Shaath is the president of Alpha Research & Development, Ltd. in White Plains, NY. He has over 30 years of experience as chairman of the chemistry department at SUNY-Purchase and the CEO of Kato Worldwide. Recently he formed a consulting company serving the cosmetic industry called ShaathMeadows Corporation (SMC) with laboratories in New York, New Jersey, Texas, Florida and Egypt. 
    Related Searches
    • chemistry
    • cosmetics
    • environmental
    • vitamin
    Related Knowledge Center
    • Sun Care
    • Actives
    Suggested For You
    Multi-Pack Solutions Multi-Pack Solutions
    Some Positive Developments In the Sun Care Industry Some Positive Developments In the Sun Care Industry
    No Dearth of Players For the Blame Game No Dearth of Players For the Blame Game
    Spotty Developments in Sun Care Spotty Developments in Sun Care
    Something’s Fishy: Salmon, Congress and FDA Something’s Fishy: Salmon, Congress and FDA
    Confidence Is Key Confidence Is Key
    Dove Debuts Curly Girl Emojis Dove Debuts Curly Girl Emojis
    Lush Is Flush with Novel Ideas Lush Is Flush with Novel Ideas
    Approving Sun Care Ingredients: What MUsT Be Done? Approving Sun Care Ingredients: What MUsT Be Done?
    Voluntary Registration Program Marks 10 Years Voluntary Registration Program Marks 10 Years
    What What's Not to Love?
    Sure-Fire Strategies for Cultivating Consumer Credibility Sure-Fire Strategies for Cultivating Consumer Credibility
    Oral Care Kit Recall Oral Care Kit Recall
    L’Oreal Paris Starts Global Outreach L’Oreal Paris Starts Global Outreach

    Related Sunscreen Filter

    • Actives | Sun Care
      The Final Monograph Is Upon Us!

      The Final Monograph Is Upon Us!

      These are difficult times for the sunscreen industry. First, we were faced with the prospects of no Final Monograph in sight and no Time and Extent Application (TEA) filters to improve the protection of US consumers especially from the UVA solar radi…
      Nadim Shaath, Alpha Research & Development Ltd 12.02.19

    • Actives | Polymers | Sun Care

      Another FDA Delay Is Coming Our Way

      What are the odds that the US Food and Drug Administration will issue the Final Monograph on November 26, 2019? The Sunscreen Innovations Act (SIA) of November 26, 2014 mandates its release within five years from that date. Additionally, the FDA rele…
      Nadim Shaath, Alpha Research & Development Ltd 06.03.19

    • Actives | Functional Ingredients | Polymers | Sun Care

      FDA Proposal: Part I Is the Wait Finally Over?

      On Feb. 26, 2019, the US FDA published a “proposed” rule that would put into effect a final monograph for non-prescription OTC sunscreen drug products.1 It is being published to comply with the Federal Food, Drug and Cosmetic Act (FD&…
      Nadim Shaath, Alpha Research & Development Ltd 04.01.19


    • Actives | Sun Care

      US Government Shutdown Imperils Reform Hopes

      Happy New Year! A new US Congress has been sworn in and, at press time, it is facing major political challenges over the border wall and ensuing federal government shutdown. Guess what will also suffer? The OTC Reform Act. As of Jan. 8, 2019, both th…
      Nadim Shaath, Alpha Research & Development Ltd 02.01.19

    • Actives | Functional Ingredients | Polymers | Sun Care

      The Sunrise & Sunset of Sunscreens

      We’re well into the dog days of summer in the Northern Hemisphere and there are lots of activities involving the use of sunscreens for protection from the scathing sun. Consumer Reports revealed its top-rated sunscreens for 2018. The Environmen…
      Nadim Shaath, Alpha Research & Development Ltd 08.03.18

    • Actives | Sun Care

      Will Hawaii Bring Down The Sunscreen Industry?

      Citing serious, long-term environmental damage to coral reefs and to the oceans, Hawaii lawmakers passed a bill in May that bans the use of two ultraviolet filters, oxybenzone and octinoxate. If this bill is signed by Hawaii’s governor, the ban…
      Nadim Shaath, Alpha Research & Development Ltd 06.01.18


    • Actives | Functional Ingredients | Polymers | Skin Care | Sun Care

      R&D Efforts Move Along Even as Regulators Stall

      I am getting tired of reporting on the developments—more accurately, the lack of developments—on sunscreen regulations in the US! The snail-paced movement toward final regulations is only contributing to the lack of reporting on the progr…
      Nadim Shaath, Alpha Research & Development Ltd 04.02.18

    • Sun Care

      Sunscreen Legislation Shows No Signs of Heating Up

      The Society of Cosmetic Chemists’ 71st Annual Scientific Meeting and Technology Showcase was held for the first time at the Times Square Westin Hotel in New York City on Dec. 11-12, 2017. The proceedings were slightly delayed on the first day d…
      Nadim Shaath, Alpha Research & Development Ltd 02.01.18

    • Actives | Sun Care

      We Need Good News And Better Research!

      It has been more than 15 years now since the first three Time and Extent Application (TEA) ingredients were filed with the US Food and Drug Administration (FDA), yet to date, no final decision has been reached. The Sunscreen Innovation Act (SIA) was…
      Nadim Shaath, Alpha Research & Development Ltd 12.01.17


    • Actives | Sun Care

      Over-the-Counter (OTC) Monograph Reform

      Congress is currently debating how to amend the Federal Food, Drug and Cosmetic Act to clarify the regulatory framework with respect to certain non-prescription drugs that are marketed without an approved new drug application. The proposed bill will…
      Nadim Shaath, Alpha Research & Development Ltd 10.02.17

    • Actives | Sun Care

      The Case for Sunscreens

      My previous column posed the question: Who needs sunscreens? The Skin Cancer Foundation (SCF) and the American Academy of Dermatology (AAD) both answer with an emphatic “Everyone!”1,2 Sunscreen use can help prevent skin cancer by protecti…
      Nadim Shaath, Alpha Research & Development Ltd 08.01.17

    • Actives | Sun Care
      Recent Developments in Sunscreens

      Recent Developments in Sunscreens

      FDA continues to treat sunscreens as drugs; expecting the full complement of drug tests that any cancer drug requires.
      Nadim Shaath, PhD, Alpha Research & Development Ltd. 04.03.17

    • Actives | Sun Care

      Some Positive Developments In the Sun Care Industry

      In my previous column (August 2016) we played the blame game in the sunscreen industry. I highlighted many of the negative developments in the industry and who was responsible for this perceived deterioration in the protection of our consumers from t…
      Nadim Shaath, Alpha Research & Development Ltd 10.03.16

    • Actives | Polymers | Sun Care | Testing

      No Dearth of Players For the Blame Game

      This column will tackle the problems with sun care protection in general. My next column will address the solutions for better sun care protection. Fifty years ago our sunscreen industry began to grow. In 1966, the consumer demanded protection from t…
      Nadim Shaath, Alpha Research & Development Ltd 08.01.16

    • Actives | Functional Ingredients | Sun Care
      A Forum for Sunscreen: Debating Better Protection

      A Forum for Sunscreen: Debating Better Protection

      Vital issues confronting the sun care market in the US will be discussed at a round table panel discussion during this month’s Sunscreen Symposium by the Florida Chapter of the Society of Cosmetic Chemists.1 It is the third time such a forum ha…
      Nadim Shaath 09.04.13

    Breaking News
    • T-Boz Launches CBD Line
    • DRF and Flowerkist Develop CBD Range
    • Offprice Show to Host Beauty Popup
    • Mary Kay Advocates for Equality
    • Derma E Adds CBD
    View Breaking News >
    CURRENT ISSUE

    December 2019

    • In Sickness & in Health
    • In Action
    • Tress Test
    • From Hollywood to Hair Color
    • Virtual Reality for Makeup Is Not Make Believe
    • Members of the Club
    • A New Era in Efficacy Testing
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Arkema: Bostik Acquires Danish Company LIP
    Axalta Adds New Epoxy Primer to Tufcote Liquid Industrial Coatings Portfolio
    Chromaflo Technologies Promotes Sergio Duenas to Country Manager of Mexico
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs World's First Single-Use Duodenoscope
    Dr. Stephen Hahn Confirmed as New FDA Leader
    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    Amgen Selects Location For R&D Facility
    Arctoris Opens Oxford R&D Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Prada & L’Oréal Sign Long-Term Licensing Deal
    Happi

    Latest Breaking News From Happi

    Cosmetic Assessments Revealed at CIR Panel
    T-Boz Launches CBD Line
    DRF and Flowerkist Develop CBD Range
    Ink World

    Latest Breaking News From Ink World

    Ripon Printers Adds Ricoh Pro C9210
    LogoJet Opens Bogota, Colombia Office
    Canon Solutions America Powers University of Notre Dame Athletics' Printing Capabilities
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    GSE products provide quality assurance for Pharmalabel
    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    DuPont to Acquire Osmosis Specialist
    Nice-Pak to Expand in Indiana
    Hospeco Launches Compact Fem Hy Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    TriMed Closes Out FDA Warning Letter
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    3D Printing Materials Market to Grow at 23.9% CAGR Through 2025: GVR
    Kyocera, TactoTek Collaborate on Injection Molded Structural Electronics Solutions
    Toray Opens R&D Innovation Center for the Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.